US Patent Issued to Incyte on April 14 for "Tetracyclic compounds as DGK inhibitors" (New Jersey, Delaware Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,722, issued on April 14, was assigned to Incyte Corp. (Wilmington, Del.).

"Tetracyclic compounds as DGK inhibitors" was invented by Joshua Hummel (Hockessin, Del.), Shicheng Shi (Princeton, N.J.) and Xiaozhao Wang (Moorestown, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides tetracyclic compounds that modulate the activity of diacylglycerol kinase (DGK), which are useful in the treatment of various diseases, including cancer."

The patent was filed on July 17, 2023, under Application No. 18/222,662.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pa...